Interferons in the treatment of multiple sclerosis: do they prevent the progression of the disease?

Affiliations

Review

G Rice et al. Arch Neurol. 1998 Dec.

. 1998 Dec;55(12):1578-80.

doi: 10.1001/archneur.55.12.1578.

¹ Department of Clinical Neurological Sciences, University of Western Ontario, University Hospital, London, Canada.

No abstract available

Comment in

Interferons should be used to treat most patients with MS.
Herndon RM, Jacobs L. Herndon RM, et al. Arch Neurol. 1998 Dec;55(12):1581-3. doi: 10.1001/archneur.55.12.1581. Arch Neurol. 1998. PMID: 9865806 No abstract available.
How does one define progression of disease in patients with relapsing-remitting multiple sclerosis?
Rudick RA. Rudick RA. Arch Neurol. 2000 Mar;57(3):425-6. doi: 10.1001/archneur.57.3.425. Arch Neurol. 2000. PMID: 10714675 No abstract available.
Interferons in the treatment of multiple sclerosis: errors and misrepresentations.
Herndon RM. Herndon RM. Arch Neurol. 2000 Mar;57(3):426-7. doi: 10.1001/archneur.57.3.426. Arch Neurol. 2000. PMID: 10714676 No abstract available.